Wissenschaftliche Arbeiten

Prof. Dr. İrfan Çiçin

318 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. A retrospective study on potential drug interactions: A single center experience

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.06.001 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  2. An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

    European Journal of Cancer, 2018

    DOI 10.1016/s0959-8049(18)30535-5 2 Zitationen (OpenAlex) Quelle: OpenAlex

  3. Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma.

    PubMed, 2018

    PMID 30358202 3 Zitationen (Europe PMC) Quelle: OpenAlex

  4. Bone-Targeted Therapy in Early Breast Cancer

    Springer eBooks, 2018

    DOI 10.1007/978-3-319-96947-3_18 1 Zitation (OpenAlex) Quelle: OpenAlex

  5. Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.4_suppl.207 99 Zitationen (OpenAlex) Quelle: OpenAlex

  6. Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.4090 26 Zitationen (OpenAlex) Quelle: OpenAlex

  7. Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.4019 13 Zitationen (OpenAlex) Quelle: OpenAlex

  8. Bone-Targeted Therapy in Advanced Breast Cancer

    Springer eBooks, 2018

    DOI 10.1007/978-3-319-96947-3_25 Quelle: OpenAlex

  9. Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e21656 Quelle: OpenAlex

  10. EFFECTIVENESS AND SAFETY OF LMWH TREATMENT IN CANCER PATIENTS DIAGNOSED WITH NON-HIGH RISK VENOUS THROMBOEMBOLISM (VTE) - RESULTS OF TURKISH OBSERVATIONAL STUDY (TREBECA)

    Bursa Uludag University - AVESIS, 2017

    Quelle: OpenAlex

  11. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

    The Lancet, 2017

    DOI 10.1016/s0140-6736(17)32365-6 PMID 28916371 125 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  12. K-RAS and N-RAS mutations in testicular germ cell tumors

    Bosnian Journal of Basic Medical Sciences, 2017

    DOI 10.17305/bjbms.2017.1764 PMID 28426398 20 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  13. Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis.

    PubMed, 2017

    PMID 28730760 2 Zitationen (Europe PMC) Quelle: OpenAlex

  14. Outcomes of Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e12517 3 Zitationen (OpenAlex) Quelle: OpenAlex

  15. Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15055 Quelle: OpenAlex

  16. İLERİ EVREKÜÇÜK HÜCRELİ DIŞIAKCİĞER KANSERİTANI VE TEDAVİ KILAVUZU

    2017

    Quelle: OpenAlex

  17. KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer

    Balkan Medical Journal, 2016

    DOI 10.5152/balkanmedj.2016.150610 PMID 27606136 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  18. Unknown primary adenocarcinomas: a single-center experience

    Bosnian Journal of Basic Medical Sciences, 2016

    DOI 10.17305/bjbms.2016.1495 PMID 27455119 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  19. The Effect of the Gastrectomy on Survival in Patients with Metastatic Gastric Cancer: A Study of ASMO

    Future Oncology, 2016

    DOI 10.2217/fon.15.304 PMID 26775722 8 Zitationen (Europe PMC) Quelle: OpenAlex

  20. A rare cause in etiology of left atrial mass: metastatic testicular germ cell tumor

    Polish Journal of Cardio-Thoracic Surgery, 2016

    DOI 10.5114/kitp.2016.58965 PMID 27212979 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  21. Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatment.

    PubMed, 2016

    PMID 27382940 3 Zitationen (Europe PMC) Quelle: OpenAlex

  22. Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas

    Balkan Medical Journal, 2016

    DOI 10.5152/balkanmedj.2016.151268 PMID 27761279 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation

    Bosnian Journal of Basic Medical Sciences, 2016

    DOI 10.17305/bjbms.2016.1380 PMID 27371767 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  24. Endometrial carcinoma and paraneoplastic immune thrombocytopenia

    Journal of Oncological Sciences, 2016

    DOI 10.1016/j.jons.2016.04.006 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  25. Bone-Directed Therapy and Breast Cancer: Bisphosphonates, Monoclonal Antibodies, and Radionuclides

    Springer eBooks, 2016

    DOI 10.1007/978-3-319-26012-9_42 Quelle: OpenAlex

  26. Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report

    Journal of Oncological Sciences, 2016

    DOI 10.1016/j.jons.2016.10.003 Frei zugänglicher VolltextQuelle: OpenAlex

  27. Metastatik Küçük Hücreli Dışı Akciğer Kanserinde Kaç Seri Kemoterapi Verilmeli

    Turkiye Klinikleri Medical Oncology - Special Topics, 2016

    Quelle: OpenAlex

  28. Germ Hücreli ve Stromal Over Kanserlerinde Sistemik Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2016

    Quelle: OpenAlex

  29. Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients.

    PubMed, 2015

    PMID 26902020 7 Zitationen (Europe PMC) Quelle: OpenAlex

  30. Comparative Analysis of the Efficacy and Safety of Oxaliplatin Plus 5-Fluorouracil/Leucovorin (Modified FOLFOX6) with Advanced Gastric Cancer Patients having a Good or Poor Performance Status

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.6.2355 PMID 25824764 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  31. Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer

    Molecular and Clinical Oncology, 2015

    DOI 10.3892/mco.2015.592 PMID 26623070 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  32. Single-agent bevacizumab is an effective treatment in recurrent glioblastoma

    Medical Oncology, 2015

    DOI 10.1007/s12032-014-0460-3 PMID 25572814 4 Zitationen (Europe PMC) Quelle: OpenAlex

  33. Increased Dose Single-agent Gemcitabine in Platinum-taxane Resistant Metastatic Ovarian Cancer

    Tumori Journal, 2015

    DOI 10.5301/tj.5000209 2 Zitationen (OpenAlex) Quelle: OpenAlex

  34. Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancer.

    PubMed, 2015

    PMID 26214624 3 Zitationen (Europe PMC) Quelle: OpenAlex

  35. Implantations of Central Venous Ports with Chest Catheter Insertion Via the Subclavian Vein in Oncology Patients: A Single Çenter Experience

    DergiPark (Istanbul University), 2015

    1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  36. Biyobenzer Ürünlerde Klinik Uygulamada Karşılaşılabilecek Sorunlar

    MARMARA PHARMACEUTCAL JOURNAL, 2015

    DOI 10.12991/mpj.20164450877 Frei zugänglicher VolltextQuelle: OpenAlex

  37. Denosumab - a Monoclonal Antibody, not a Radionuclide

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.5.2103 PMID 25773858 Frei zugänglicher VolltextQuelle: OpenAlex

  38. Turkish National Gastric Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12645 Frei zugänglicher VolltextQuelle: OpenAlex

  39. Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12654 Quelle: OpenAlex

  40. Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12657 Quelle: OpenAlex

  41. Turkish National Colon Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12646 Frei zugänglicher VolltextQuelle: OpenAlex

  42. Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12656 Quelle: OpenAlex

  43. Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15056 Frei zugänglicher VolltextQuelle: OpenAlex

  44. Turkish National Breast Cancer Registry

    AYBU AVESIS, 2015

    Quelle: OpenAlex

  45. Association of obesity with breast cancer clinical and pathological factors Analysis of Turkish National Breast Cancer Registry

    AYBU AVESIS, 2015

    Quelle: OpenAlex

  46. Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors

    Molecular and Clinical Oncology, 2014

    DOI 10.3892/mco.2014.448 PMID 25469291 21 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  47. Medical Treatment of Breast Cancer Bone Metastasis: From Bisphosphonates to Targeted Drugs

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.4.1503 PMID 24641358 18 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  48. A rarely seen mucoepidermoid carcinoma of the left main bronchus

    Journal of Cancer Research and Therapeutics, 2014

    DOI 10.4103/0973-1482.136665 PMID 25022400 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  49. Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancer

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0441-6 PMID 25502088 4 Zitationen (Europe PMC) Quelle: OpenAlex

  50. Kastrasyona Dirençli Prostat Kanserinde Kemoterapi ve Hedefe Yönelik Tedavi

    Turkiye Klinikleri Urology - Special Topics, 2014

    Quelle: OpenAlex